Previous studies showed that TGF‐β‐induced Smad3 activation repressed TERT expression by directly binding to TERT gene's promoter and inhibiting its transcription in breast cancer cell line MCF‐7.47, 48. This evidence concerns the gene TGFB1 and breast cancer.